0 CHECKOUT

PRODUCT FILTERS

REGION

213
138
137
115
115

COUNTRY

107
32
23
15
15

PRICE

56
265
441
1,136

PUBLISHED

246
303
545
1,136

PRODUCT TYPE

1,084
49
2
1

Central Nervous System

In 2012 major changes might revolutionize the treatment of multiple sclerosis, as Gilenya, the first novel drug in five years, will be joined by three new products: BG-12, Aubagio, and Lemtrada. Recent exciting developments in drug discovery might also enhance the hopes of those fighting against Alzheimer.

Great commercial and scientific opportunities are to be found in similar battles against a range of diseases and neurodegenerative disorders, e.g. Parkinson’s disease, schizophrenia, migraine, insomnia, epilepsy, etc.

A wide selection of industry reports, scientific journals and academic textbooks in this section allow readers to explore every conceivable facet of this industry, such as market trends, industry forecasts, new drugs in development, the latest research & development, patent applications, and licensing strategies.

Key players featured in our publications include Biogen Idec, Sanofi, Genzyme, and many more. Show Less
Read more

Meningitis-API Insights

Summary Meningitis-API Insights, 2015 report provides Meningitis drugs marketed details and API Manufacturers details across the globe along with the location. The report gives the clear idea on...

Published:  February 2016
Price:  From

Vimpat -Drug Insights, 2016

Drug Report, “Vimpat- Drug Insights, 2016” highlights the Vimpat marketed details, pipeline status and the Global API Manufacturers along with the location. The report covers the Global Market Assessment...

Published:  February 2016
Price:  From

Traumatic Brain Injury-Pipeline Insights, 2016

“ Traumatic Brain Injury-Pipeline Insights, 2016” provides in depth insight on the pipeline drugs and their development activities around the Traumatic Brain Injury. The report covers the product...

Published:  February 2016
Price:  From

Requip IR -Drug Insights, 2016

Drug Report, “Requip IR- Drug Insights, 2016” highlights the Requip IR marketed details, pipeline status and the Global API Manufacturers along with the location. The report covers the Global Market...

Published:  February 2016
Price:  From

Restless Legs Syndrome-Pipeline Insights, 2016

“ Restless Legs Syndrome-Pipeline Insights, 2016” provides in depth insight on the pipeline drugs and their development activities around the Restless Legs Syndrome. The report covers the product...

Published:  February 2016
Price:  From

Postherpetic Neuralgia-Pipeline Insights, 2016

“ Postherpetic Neuralgia-Pipeline Insights, 2016” provides in depth insight on the pipeline drugs and their development activities around the Postherpetic Neuralgia. The report covers the product...

Published:  February 2016
Price:  From

Secondary Progressive Multiple Sclerosis (SPMS)-Pipeline Insights, 2016

“ Secondary Progressive Multiple Sclerosis (SPMS)-Pipeline Insights, 2016” provides in depth insight on the pipeline drugs and their development activities around the Secondary Progressive Multiple...

Published:  February 2016
Price:  From

Primary Progressive Multiple Sclerosis (PPMS)-Pipeline Insights, 2016

“ Primary Progressive Multiple Sclerosis (PPMS)-Pipeline Insights, 2016” provides in depth insight on the pipeline drugs and their development activities around the Primary Progressive Multiple Sclerosis...

Published:  February 2016
Price:  From

Restless Legs Syndrome-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

SUMMARY The Report, “Restless Legs Syndrome-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III...

Published:  February 2016
Price:  From

Postherpetic Neuralgia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

SUMMARY The Report, “Postherpetic Neuralgia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III...

Published:  February 2016
Price:  From

Neuralgia-Pipeline Insights, 2016

“ Neuralgia-Pipeline Insights, 2016” provides in depth insight on the pipeline drugs and their development activities around the Neuralgia. The report covers the product profiles in various stages...

Published:  February 2016
Price:  From

Dementia Associated With Alzheimer's Disease-Pipeline Insights, 2016

“ Dementia Associated With Alzheimer's Disease-Pipeline Insights, 2016” provides in depth insight on the pipeline drugs and their development activities around the Dementia Associated With Alzheimer's...

Published:  February 2016
Price:  From

Japanese Encephalitis-Pipeline Insights, 2016

“ Japanese Encephalitis-Pipeline Insights, 2016” provides in depth insight on the pipeline drugs and their development activities around the Japanese Encephalitis. The report covers the product profiles...

Published:  February 2016
Price:  From

Migraine-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

SUMMARY The Report, “Migraine-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs...

Published:  February 2016
Price:  From

Dementia Associated With Alzheimer's Disease-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

SUMMARY The Report, “Dementia Associated With Alzheimer's Disease-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs,...

Published:  February 2016
Price:  From

Nerve Growth Factor (NGF) Inhibitors -Pipeline Insights, 2016

SUMMARY The report, “Nerve Growth Factor (NGF) Inhibitors-Pipeline Insights, 2016” provides in depth insights on the pipeline drugs and their development activities around the Nerve Growth Factor...

Published:  February 2016
Price:  From

Pneumococcal Meningitis-Pipeline Insights, 2016

“ Pneumococcal Meningitis-Pipeline Insights, 2016” provides in depth insight on the pipeline drugs and their development activities around the Pneumococcal Meningitis. The report covers the product...

Published:  February 2016
Price:  From

Bacterial (Pyogenic) Meningitis-Pipeline Insights, 2016

“ Bacterial (Pyogenic) Meningitis-Pipeline Insights, 2016” provides in depth insight on the pipeline drugs and their development activities around the Bacterial (Pyogenic) Meningitis. The report...

Published:  February 2016
Price:  From

Relapsing Remitting Multiple Sclerosis (RRMS)-Pipeline Insights, 2016

“ Relapsing Remitting Multiple Sclerosis (RRMS)-Pipeline Insights, 2016” provides in depth insight on the pipeline drugs and their development activities around the Relapsing Remitting Multiple Sclerosis...

Published:  February 2016
Price:  From

Relapsing Multiple Sclerosis (RMS)-Pipeline Insights, 2016

“ Relapsing Multiple Sclerosis (RMS)-Pipeline Insights, 2016” provides in depth insight on the pipeline drugs and their development activities around the Relapsing Multiple Sclerosis (RMS). The report...

Published:  February 2016
Price:  From
Loading Indicator

Our Clients